Ganglioglioma
9
3
5
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 9 trials
100.0%
+13.4% vs benchmark
11%
1 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (9)
Social Determinants of Health in Glioblastoma Population
Pediatric Long-Term Follow-up and Rollover Study
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2
Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation
Exploration and Evaluation of Amygdalo-Hippocampectomy According to Prof. Coubes' Technique: An Anatomical, Clinical, and Educational Approach
Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology
Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors
Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors